论文部分内容阅读
肾移植已成为多数终末期肾衰患者的重要治疗方法。受体抗供体试管法淋巴细胞毒抗体试验（简称淋巴细胞毒抗体试验，以下同）是在肾移植前检测受肾者（患者），血清中是否存在抗不同基因型白细胞抗体（细胞毒）的一种重要试验［1］。如果受者对准备移植的供者淋巴细胞，具有特异
Kidney transplantation has become an important treatment for most patients with end-stage renal failure. Receptor Antagonistic In Vivo Lymphocyte Antibody Assay (referred to as Lymphocyte Antibody Assay, hereinafter the same) refers to the detection of recipients (patients) before kidney transplantation and the presence or absence of anti-leukocyte antibody (cytotoxic) An important test [1]. Specific to the recipient’s donor lymphocytes to be transplanted